Cargando…
HRAS germline mutations impair LKB1/AMPK signaling and mitochondrial homeostasis in Costello syndrome models
Germline mutations that activate genes in the canonical RAS/MAPK signaling pathway are responsible for rare human developmental disorders known as RASopathies. Here, we analyzed the molecular determinants of Costello syndrome (CS) using a mouse model expressing HRAS p.G12S, patient skin fibroblasts,...
Autores principales: | Dard, Laetitia, Hubert, Christophe, Esteves, Pauline, Blanchard, Wendy, Bou About, Ghina, Baldasseroni, Lyla, Dumon, Elodie, Angelini, Chloe, Delourme, Mégane, Guyonnet-Dupérat, Véronique, Claverol, Stéphane, Fontenille, Laura, Kissa, Karima, Séguéla, Pierre-Emmanuel, Thambo, Jean-Benoît, Nicolas, Lévy, Herault, Yann, Bellance, Nadège, Dias Amoedo, Nivea, Magdinier, Frédérique, Sorg, Tania, Lacombe, Didier, Rossignol, Rodrigue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012293/ https://www.ncbi.nlm.nih.gov/pubmed/35230976 http://dx.doi.org/10.1172/JCI131053 |
Ejemplares similares
-
The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in Cancer
por: Hartung, Anne-Mette, et al.
Publicado: (2016) -
Increased osteoclastogenesis contributes to bone loss in the Costello syndrome Hras G12V mouse model
por: Nandi, Sayantan, et al.
Publicado: (2022) -
Neonatal Lethal Costello Syndrome and Unusual Dinucleotide Deletion/Insertion Mutations in HRAS Predicting p.Gly12Val
por: Burkitt-Wright, Emma MM, et al.
Publicado: (2012) -
MEK-inhibitor-mediated rescue of skeletal myopathy caused by activating Hras mutation in a Costello syndrome mouse model
por: Tidyman, William E., et al.
Publicado: (2021) -
Costello syndrome with special cutaneous manifestations and HRAS G12D mutation: A case report and literature review
por: Qian, Wen, et al.
Publicado: (2021)